echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Ann Intern Med: Long-term use of fast-acting promethazine does not slow down the clinical progression of early Parkinson's disease

    Ann Intern Med: Long-term use of fast-acting promethazine does not slow down the clinical progression of early Parkinson's disease

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Studies have shown that dihydropyridine calcium channel blockers may be associated with a reduced risk of Parkinson's disease (PD).


    The 57 Parkinson’s research team sites in North America included patients with early Parkinson’s disease (duration <3 years) who were not taking dopaminergic drugs at the time of enrollment and were randomized to receive 5 mg promethazine or placebo twice a day.


     

    A total of 336 patients were randomized (mean age 62 years [SD, 9]; 68% were male; disease duration 0.


     

    After adjusting the average of least squares, the total UPDRS score changes of promethazine and placebo recipients under the anti-Parkinson drug ON state within 36 months were 2.


    In summary, the results of this study show that long-term use of fast-acting promethazine cannot slow down the clinical progression of early PD.


     

    Original source:

     

    Parkinson Study Group STEADY-PD III Investigators.


    Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.